US Broker Ratings

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 269.75% Potential Upside Entices Investors

Akebia Therapeutics, Inc. (NASDAQ: AKBA) has emerged as a compelling player in the healthcare sector, specifically within the specialized niche of drug manufacturing for kidney-related ailments. With a market capitalization..

Mind Medicine (MNMD) Stock Analysis: A 90% Upside Opportunity in the Biotech Sector

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is capturing investor interest with its innovative approach to treating brain health disorders. With a current market capitalization of $1.46..

Savara, Inc. (SVRA) Stock Analysis: Potential Upside Nearing 97% as Analysts Rally Behind Biotech Innovator

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its focus on rare respiratory diseases. Headquartered in Langhorne, Pennsylvania, Savara’s primary product, molgramostim,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Through Challenges with Strategic Positioning

Avanos Medical, Inc. (NYSE: AVNS), a significant player in the healthcare sector, particularly in the medical devices industry, is a company that demands attention from investors who have an eye..

Cronos Group Inc. (CRON) Stock Analysis: A High Growth Cannabis Player with Strategic Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabis sector, is drawing attention with its significant revenue growth but faces strategic challenges that warrant a closer look from..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 19.88% Potential Upside in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the medical devices sector, has been capturing investor attention with its strategic focus on MRI-compatible medical devices. As a United States-based company..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Navigating a 155% Potential Upside Amidst Revolutionary Biotech Advances

AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, has been capturing investor attention with a substantial 155.34% potential upside as suggested by analyst ratings. Headquartered in..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Biotech with 97% Potential Upside

Nurix Therapeutics, Inc. (NRIX) is making waves in the biotechnology sector with its promising pipeline of innovative therapies targeting cancer and inflammatory conditions. With a market capitalization of $1.57 billion,..

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a Potential 159% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a burgeoning player in the healthcare sector, is capturing investor attention with its impressive potential upside of 159.13%, according to analyst target price ranges. Specializing in..

CeriBell, Inc. (CBLL) Stock Analysis: A 55% Potential Upside Amid Strong Buy Ratings

CeriBell, Inc. (NASDAQ: CBLL) is capturing significant attention in the healthcare sector, particularly within the medical devices industry. This United States-based company, with a market capitalization of $673.4 million, is..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A 40.95% Upside Potential in the Biotech Sector

Investors seeking promising opportunities in the biotechnology sector might find Enliven Therapeutics, Inc. (NASDAQ: ELVN) particularly intriguing. With a current market capitalization of $1.74 billion, this Boulder, Colorado-based company is..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A High-Risk, High-Reward Bet in Gene Editing with 92% Upside Potential

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is capturing the attention of investors with its cutting-edge approach to genome editing. As a clinical-stage company, Intellia is at the forefront of developing potentially..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 21.60% Upside Potential Amidst Clinical Innovations

Arbutus Biopharma Corporation (NASDAQ: ABUS), a prominent player in the biotechnology sector, is capturing investor attention with its promising clinical-stage therapeutics and a notable 21.60% potential upside. Headquartered in Warminster,..

Anavex Life Sciences Corp. (AVXL) Investor Outlook: Exploring a Potential 362% Upside in Biotech

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company headquartered in New York, is making waves in the biotechnology sector with its innovative approach to treating central nervous system (CNS)..

Arcus Biosciences, Inc. (RCUS)

⚠️ No article content returned.

..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 76% Potential Upside in the Healthcare Sector

For investors keen on tapping into the healthcare sector, Embecta Corp. (NASDAQ: EMBC) offers an intriguing proposition with a potential upside of 76.55%. This Parsippany, New Jersey-based medical device company..

Praxis Precision Medicines (PRAX) Stock Analysis: A Biotech with 93% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. With its focus on developing precision therapies for central nervous..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 153% Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Nuvation Bio Inc. (NYSE: NUVB) an intriguing prospect, especially given its impressive potential upside. With a current market cap of..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising Growth Potential with a 110.77% Upside

Beta Bionics, Inc. (NASDAQ: BBNX), a dynamic player in the healthcare sector, is capturing the attention of investors with its innovative approach to diabetes management. The company, based in Irvine,..

Weave Communications, Inc. (WEAV) Stock Analysis: Unveiling a Significant 57.94% Upside Potential

Weave Communications, Inc. (NYSE: WEAV) is garnering attention from investors, thanks in part to its substantial 57.94% potential upside, according to analyst ratings. Specializing in health information services, Weave Communications..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds